Glenmark Pharmaceuticals Ltd.

NSE: GLENMARK | BSE: 532296

Mid-range Performer

In 2 Starfolio Baskets

Download real time

2252.40 -40.60 (-1.77%)

25.65% Gain from 52W Low

197.5K

NSE+BSE Volume

NSE 12 Oct, 2026 11:55 AM (IST)

Glenmark Pharma News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Glenmark Pharma from all sources in a single place.

Is Glenmark Pharmaceuticals Ltd. worth buying?

581 Votes:

Buy 79.52%

Sell 13.6%

Hold 6.88%

RESEARCH REPORTS

Accumulate SEE REPORTS >

Hold SEE REPORTS >